GSI treatment after cerebral ischemia do not alter the total number of reactive astrocytes (GFAP+), but reduce the number of RC2+ astrocytes and the number of proliferative reactive astrocytes (GFAP+ KI67+). Here, MKI67 is linked to brain ischemia.